nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydromorphone—Low back pain—Lisinopril—dilated cardiomyopathy	0.0399	0.0423	CcSEcCtD
Hydromorphone—Instillation site pain—Furosemide—dilated cardiomyopathy	0.0237	0.0251	CcSEcCtD
Hydromorphone—Uremia—Lisinopril—dilated cardiomyopathy	0.0229	0.0243	CcSEcCtD
Hydromorphone—Incontinence—Furosemide—dilated cardiomyopathy	0.0221	0.0234	CcSEcCtD
Hydromorphone—Hypotensive—Furosemide—dilated cardiomyopathy	0.0212	0.0224	CcSEcCtD
Hydromorphone—Application site pain—Furosemide—dilated cardiomyopathy	0.0176	0.0186	CcSEcCtD
Hydromorphone—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.013	0.0138	CcSEcCtD
Hydromorphone—Appetite absent—Lisinopril—dilated cardiomyopathy	0.0116	0.0123	CcSEcCtD
Hydromorphone—Azotaemia—Lisinopril—dilated cardiomyopathy	0.0109	0.0115	CcSEcCtD
Hydromorphone—Apathy—Furosemide—dilated cardiomyopathy	0.0108	0.0114	CcSEcCtD
Hydromorphone—Flat affect—Furosemide—dilated cardiomyopathy	0.0107	0.0113	CcSEcCtD
Hydromorphone—Lethargy—Spironolactone—dilated cardiomyopathy	0.0105	0.0111	CcSEcCtD
Hydromorphone—Injection site pain—Furosemide—dilated cardiomyopathy	0.00946	0.01	CcSEcCtD
Hydromorphone—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00928	0.00983	CcSEcCtD
Hydromorphone—Gastritis—Spironolactone—dilated cardiomyopathy	0.00912	0.00966	CcSEcCtD
Hydromorphone—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.00892	0.00944	CcSEcCtD
Hydromorphone—Drug interaction—Furosemide—dilated cardiomyopathy	0.00833	0.00882	CcSEcCtD
Hydromorphone—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.00833	0.00882	CcSEcCtD
Hydromorphone—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.0082	0.00869	CcSEcCtD
Hydromorphone—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00794	0.00841	CcSEcCtD
Hydromorphone—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00787	0.00833	CcSEcCtD
Hydromorphone—Memory impairment—Lisinopril—dilated cardiomyopathy	0.00738	0.00782	CcSEcCtD
Hydromorphone—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.00715	0.00757	CcSEcCtD
Hydromorphone—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.0071	0.00751	CcSEcCtD
Hydromorphone—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.00699	0.0074	CcSEcCtD
Hydromorphone—Urine output increased—Furosemide—dilated cardiomyopathy	0.00698	0.00739	CcSEcCtD
Hydromorphone—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00691	0.00732	CcSEcCtD
Hydromorphone—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.00655	0.00694	CcSEcCtD
Hydromorphone—Accidental injury—Lisinopril—dilated cardiomyopathy	0.00655	0.00694	CcSEcCtD
Hydromorphone—Polyuria—Furosemide—dilated cardiomyopathy	0.00639	0.00676	CcSEcCtD
Hydromorphone—Arthropathy—Lisinopril—dilated cardiomyopathy	0.00637	0.00675	CcSEcCtD
Hydromorphone—Swelling—Furosemide—dilated cardiomyopathy	0.00636	0.00673	CcSEcCtD
Hydromorphone—Oliguria—Lisinopril—dilated cardiomyopathy	0.00629	0.00666	CcSEcCtD
Hydromorphone—Drug interaction—Lisinopril—dilated cardiomyopathy	0.00625	0.00662	CcSEcCtD
Hydromorphone—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00597	0.00632	CcSEcCtD
Hydromorphone—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.0058	0.00614	CcSEcCtD
Hydromorphone—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00579	0.00613	CcSEcCtD
Hydromorphone—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00576	0.0061	CcSEcCtD
Hydromorphone—Lethargy—Furosemide—dilated cardiomyopathy	0.00572	0.00606	CcSEcCtD
Hydromorphone—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00563	0.00596	CcSEcCtD
Hydromorphone—Wheezing—Lisinopril—dilated cardiomyopathy	0.00563	0.00596	CcSEcCtD
Hydromorphone—Malaise—Spironolactone—dilated cardiomyopathy	0.0056	0.00593	CcSEcCtD
Hydromorphone—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00556	0.00588	CcSEcCtD
Hydromorphone—Fluid retention—Lisinopril—dilated cardiomyopathy	0.0055	0.00583	CcSEcCtD
Hydromorphone—Urinary retention—Furosemide—dilated cardiomyopathy	0.00533	0.00565	CcSEcCtD
Hydromorphone—Discomfort—Spironolactone—dilated cardiomyopathy	0.00522	0.00553	CcSEcCtD
Hydromorphone—Dehydration—Furosemide—dilated cardiomyopathy	0.00521	0.00552	CcSEcCtD
Hydromorphone—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00519	0.00549	CcSEcCtD
Hydromorphone—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.00516	0.00546	CcSEcCtD
Hydromorphone—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00512	0.00542	CcSEcCtD
Hydromorphone—Confusional state—Spironolactone—dilated cardiomyopathy	0.00511	0.00541	CcSEcCtD
Hydromorphone—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00507	0.00536	CcSEcCtD
Hydromorphone—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00505	0.00535	CcSEcCtD
Hydromorphone—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00495	0.00524	CcSEcCtD
Hydromorphone—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00488	0.00517	CcSEcCtD
Hydromorphone—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00475	0.00503	CcSEcCtD
Hydromorphone—Injury—Lisinopril—dilated cardiomyopathy	0.00458	0.00485	CcSEcCtD
Hydromorphone—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00454	0.0048	CcSEcCtD
Hydromorphone—Somnolence—Spironolactone—dilated cardiomyopathy	0.0045	0.00477	CcSEcCtD
Hydromorphone—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00448	0.00474	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00437	0.00463	CcSEcCtD
Hydromorphone—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00435	0.0046	CcSEcCtD
Hydromorphone—Drowsiness—Furosemide—dilated cardiomyopathy	0.00432	0.00458	CcSEcCtD
Hydromorphone—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00422	0.00447	CcSEcCtD
Hydromorphone—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00421	0.00445	CcSEcCtD
Hydromorphone—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00421	0.00445	CcSEcCtD
Hydromorphone—Diplopia—Lisinopril—dilated cardiomyopathy	0.00421	0.00445	CcSEcCtD
Hydromorphone—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00417	0.00442	CcSEcCtD
Hydromorphone—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00417	0.00442	CcSEcCtD
Hydromorphone—Sweating—Furosemide—dilated cardiomyopathy	0.00414	0.00439	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00409	0.00433	CcSEcCtD
Hydromorphone—Urticaria—Spironolactone—dilated cardiomyopathy	0.00402	0.00426	CcSEcCtD
Hydromorphone—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.004	0.00424	CcSEcCtD
Hydromorphone—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.004	0.00424	CcSEcCtD
Hydromorphone—Dehydration—Lisinopril—dilated cardiomyopathy	0.00391	0.00414	CcSEcCtD
Hydromorphone—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00384	0.00407	CcSEcCtD
Hydromorphone—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00383	0.00406	CcSEcCtD
Hydromorphone—Urethral disorder—Furosemide—dilated cardiomyopathy	0.0038	0.00403	CcSEcCtD
Hydromorphone—Breast disorder—Lisinopril—dilated cardiomyopathy	0.0038	0.00403	CcSEcCtD
Hydromorphone—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00379	0.00401	CcSEcCtD
Hydromorphone—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00376	0.00398	CcSEcCtD
Hydromorphone—Visual impairment—Furosemide—dilated cardiomyopathy	0.00374	0.00396	CcSEcCtD
Hydromorphone—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00373	0.00395	CcSEcCtD
Hydromorphone—Gastritis—Lisinopril—dilated cardiomyopathy	0.00372	0.00394	CcSEcCtD
Hydromorphone—Asthma—Lisinopril—dilated cardiomyopathy	0.00364	0.00385	CcSEcCtD
Hydromorphone—Eye disorder—Furosemide—dilated cardiomyopathy	0.00363	0.00384	CcSEcCtD
Hydromorphone—Tinnitus—Furosemide—dilated cardiomyopathy	0.00362	0.00383	CcSEcCtD
Hydromorphone—Pruritus—Spironolactone—dilated cardiomyopathy	0.00358	0.00379	CcSEcCtD
Hydromorphone—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00358	0.00379	CcSEcCtD
Hydromorphone—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00354	0.00375	CcSEcCtD
Hydromorphone—Angiopathy—Furosemide—dilated cardiomyopathy	0.00352	0.00373	CcSEcCtD
Hydromorphone—Immune system disorder—Furosemide—dilated cardiomyopathy	0.0035	0.00371	CcSEcCtD
Hydromorphone—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00347	0.00367	CcSEcCtD
Hydromorphone—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00347	0.00367	CcSEcCtD
Hydromorphone—Dysuria—Lisinopril—dilated cardiomyopathy	0.0034	0.0036	CcSEcCtD
Hydromorphone—Malnutrition—Furosemide—dilated cardiomyopathy	0.00338	0.00358	CcSEcCtD
Hydromorphone—Erythema—Furosemide—dilated cardiomyopathy	0.00338	0.00358	CcSEcCtD
Hydromorphone—Dizziness—Spironolactone—dilated cardiomyopathy	0.00335	0.00355	CcSEcCtD
Hydromorphone—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00335	0.00355	CcSEcCtD
Hydromorphone—Flatulence—Furosemide—dilated cardiomyopathy	0.00333	0.00352	CcSEcCtD
Hydromorphone—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00331	0.0035	CcSEcCtD
Hydromorphone—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00329	0.00348	CcSEcCtD
Hydromorphone—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00325	0.00344	CcSEcCtD
Hydromorphone—Depression—Lisinopril—dilated cardiomyopathy	0.00323	0.00342	CcSEcCtD
Hydromorphone—Vomiting—Spironolactone—dilated cardiomyopathy	0.00322	0.00341	CcSEcCtD
Hydromorphone—Rash—Spironolactone—dilated cardiomyopathy	0.00319	0.00338	CcSEcCtD
Hydromorphone—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00319	0.00338	CcSEcCtD
Hydromorphone—Vision blurred—Furosemide—dilated cardiomyopathy	0.00318	0.00337	CcSEcCtD
Hydromorphone—Headache—Spironolactone—dilated cardiomyopathy	0.00317	0.00336	CcSEcCtD
Hydromorphone—Sweating—Lisinopril—dilated cardiomyopathy	0.00311	0.00329	CcSEcCtD
Hydromorphone—Agitation—Furosemide—dilated cardiomyopathy	0.0031	0.00329	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00307	0.00325	CcSEcCtD
Hydromorphone—Vertigo—Furosemide—dilated cardiomyopathy	0.00303	0.00321	CcSEcCtD
Hydromorphone—Leukopenia—Furosemide—dilated cardiomyopathy	0.00302	0.0032	CcSEcCtD
Hydromorphone—Nausea—Spironolactone—dilated cardiomyopathy	0.00301	0.00319	CcSEcCtD
Hydromorphone—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00296	0.00314	CcSEcCtD
Hydromorphone—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00292	0.00309	CcSEcCtD
Hydromorphone—Hallucination—Lisinopril—dilated cardiomyopathy	0.0029	0.00307	CcSEcCtD
Hydromorphone—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00287	0.00304	CcSEcCtD
Hydromorphone—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00287	0.00304	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00286	0.00302	CcSEcCtD
Hydromorphone—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00285	0.00302	CcSEcCtD
Hydromorphone—Dry mouth—Furosemide—dilated cardiomyopathy	0.00281	0.00298	CcSEcCtD
Hydromorphone—Confusional state—Furosemide—dilated cardiomyopathy	0.00278	0.00294	CcSEcCtD
Hydromorphone—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00276	0.00292	CcSEcCtD
Hydromorphone—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00271	0.00287	CcSEcCtD
Hydromorphone—Shock—Furosemide—dilated cardiomyopathy	0.00271	0.00287	CcSEcCtD
Hydromorphone—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.0027	0.00286	CcSEcCtD
Hydromorphone—Flushing—Lisinopril—dilated cardiomyopathy	0.0027	0.00286	CcSEcCtD
Hydromorphone—Skin disorder—Furosemide—dilated cardiomyopathy	0.00268	0.00283	CcSEcCtD
Hydromorphone—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00266	0.00282	CcSEcCtD
Hydromorphone—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00264	0.0028	CcSEcCtD
Hydromorphone—Anorexia—Furosemide—dilated cardiomyopathy	0.00263	0.00278	CcSEcCtD
Hydromorphone—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00262	0.00278	CcSEcCtD
Hydromorphone—Chills—Lisinopril—dilated cardiomyopathy	0.00261	0.00277	CcSEcCtD
Hydromorphone—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.0026	0.00275	CcSEcCtD
Hydromorphone—Hypotension—Furosemide—dilated cardiomyopathy	0.00258	0.00273	CcSEcCtD
Hydromorphone—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00255	0.0027	CcSEcCtD
Hydromorphone—Erythema—Lisinopril—dilated cardiomyopathy	0.00253	0.00268	CcSEcCtD
Hydromorphone—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00253	0.00268	CcSEcCtD
Hydromorphone—Flatulence—Lisinopril—dilated cardiomyopathy	0.0025	0.00264	CcSEcCtD
Hydromorphone—Tension—Lisinopril—dilated cardiomyopathy	0.00249	0.00263	CcSEcCtD
Hydromorphone—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00248	0.00263	CcSEcCtD
Hydromorphone—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00247	0.00262	CcSEcCtD
Hydromorphone—Nervousness—Lisinopril—dilated cardiomyopathy	0.00246	0.00261	CcSEcCtD
Hydromorphone—Back pain—Lisinopril—dilated cardiomyopathy	0.00245	0.00259	CcSEcCtD
Hydromorphone—Somnolence—Furosemide—dilated cardiomyopathy	0.00245	0.00259	CcSEcCtD
Hydromorphone—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00244	0.00258	CcSEcCtD
Hydromorphone—Decreased appetite—Furosemide—dilated cardiomyopathy	0.0024	0.00254	CcSEcCtD
Hydromorphone—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00239	0.00253	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00238	0.00252	CcSEcCtD
Hydromorphone—Fatigue—Furosemide—dilated cardiomyopathy	0.00238	0.00252	CcSEcCtD
Hydromorphone—Tremor—Lisinopril—dilated cardiomyopathy	0.00237	0.00251	CcSEcCtD
Hydromorphone—Pain—Furosemide—dilated cardiomyopathy	0.00236	0.0025	CcSEcCtD
Hydromorphone—Constipation—Furosemide—dilated cardiomyopathy	0.00236	0.0025	CcSEcCtD
Hydromorphone—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00235	0.00249	CcSEcCtD
Hydromorphone—Angioedema—Lisinopril—dilated cardiomyopathy	0.00232	0.00245	CcSEcCtD
Hydromorphone—Malaise—Lisinopril—dilated cardiomyopathy	0.00228	0.00242	CcSEcCtD
Hydromorphone—Vertigo—Lisinopril—dilated cardiomyopathy	0.00228	0.00241	CcSEcCtD
Hydromorphone—Syncope—Lisinopril—dilated cardiomyopathy	0.00227	0.00241	CcSEcCtD
Hydromorphone—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00227	0.0024	CcSEcCtD
Hydromorphone—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00227	0.0024	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00225	0.00239	CcSEcCtD
Hydromorphone—Palpitations—Lisinopril—dilated cardiomyopathy	0.00224	0.00237	CcSEcCtD
Hydromorphone—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00223	0.00236	CcSEcCtD
Hydromorphone—Cough—Lisinopril—dilated cardiomyopathy	0.00221	0.00234	CcSEcCtD
Hydromorphone—Urticaria—Furosemide—dilated cardiomyopathy	0.00219	0.00232	CcSEcCtD
Hydromorphone—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00218	0.00231	CcSEcCtD
Hydromorphone—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00218	0.00231	CcSEcCtD
Hydromorphone—Chest pain—Lisinopril—dilated cardiomyopathy	0.00216	0.00228	CcSEcCtD
Hydromorphone—Myalgia—Lisinopril—dilated cardiomyopathy	0.00216	0.00228	CcSEcCtD
Hydromorphone—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00216	0.00228	CcSEcCtD
Hydromorphone—Anxiety—Lisinopril—dilated cardiomyopathy	0.00215	0.00228	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00214	0.00227	CcSEcCtD
Hydromorphone—Discomfort—Lisinopril—dilated cardiomyopathy	0.00213	0.00226	CcSEcCtD
Hydromorphone—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00211	0.00223	CcSEcCtD
Hydromorphone—Confusional state—Lisinopril—dilated cardiomyopathy	0.00209	0.00221	CcSEcCtD
Hydromorphone—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00207	0.00219	CcSEcCtD
Hydromorphone—Infection—Lisinopril—dilated cardiomyopathy	0.00205	0.00218	CcSEcCtD
Hydromorphone—Shock—Lisinopril—dilated cardiomyopathy	0.00203	0.00215	CcSEcCtD
Hydromorphone—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00203	0.00215	CcSEcCtD
Hydromorphone—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00202	0.00214	CcSEcCtD
Hydromorphone—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00201	0.00213	CcSEcCtD
Hydromorphone—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.002	0.00212	CcSEcCtD
Hydromorphone—Asthenia—Furosemide—dilated cardiomyopathy	0.00198	0.00209	CcSEcCtD
Hydromorphone—Anorexia—Lisinopril—dilated cardiomyopathy	0.00197	0.00209	CcSEcCtD
Hydromorphone—Pruritus—Furosemide—dilated cardiomyopathy	0.00195	0.00206	CcSEcCtD
Hydromorphone—Hypotension—Lisinopril—dilated cardiomyopathy	0.00193	0.00205	CcSEcCtD
Hydromorphone—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00189	0.002	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00188	0.00199	CcSEcCtD
Hydromorphone—Insomnia—Lisinopril—dilated cardiomyopathy	0.00187	0.00198	CcSEcCtD
Hydromorphone—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00186	0.00197	CcSEcCtD
Hydromorphone—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00184	0.00195	CcSEcCtD
Hydromorphone—Somnolence—Lisinopril—dilated cardiomyopathy	0.00184	0.00195	CcSEcCtD
Hydromorphone—Dizziness—Furosemide—dilated cardiomyopathy	0.00182	0.00193	CcSEcCtD
Hydromorphone—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00182	0.00193	CcSEcCtD
Hydromorphone—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.0018	0.0019	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00179	0.00189	CcSEcCtD
Hydromorphone—Fatigue—Lisinopril—dilated cardiomyopathy	0.00178	0.00189	CcSEcCtD
Hydromorphone—Constipation—Lisinopril—dilated cardiomyopathy	0.00177	0.00187	CcSEcCtD
Hydromorphone—Pain—Lisinopril—dilated cardiomyopathy	0.00177	0.00187	CcSEcCtD
Hydromorphone—Vomiting—Furosemide—dilated cardiomyopathy	0.00175	0.00186	CcSEcCtD
Hydromorphone—Rash—Furosemide—dilated cardiomyopathy	0.00174	0.00184	CcSEcCtD
Hydromorphone—Dermatitis—Furosemide—dilated cardiomyopathy	0.00174	0.00184	CcSEcCtD
Hydromorphone—Headache—Furosemide—dilated cardiomyopathy	0.00173	0.00183	CcSEcCtD
Hydromorphone—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.0017	0.0018	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00169	0.00179	CcSEcCtD
Hydromorphone—Urticaria—Lisinopril—dilated cardiomyopathy	0.00164	0.00174	CcSEcCtD
Hydromorphone—Nausea—Furosemide—dilated cardiomyopathy	0.00164	0.00173	CcSEcCtD
Hydromorphone—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00163	0.00173	CcSEcCtD
Hydromorphone—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00163	0.00173	CcSEcCtD
Hydromorphone—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00152	0.00161	CcSEcCtD
Hydromorphone—Asthenia—Lisinopril—dilated cardiomyopathy	0.00148	0.00157	CcSEcCtD
Hydromorphone—Pruritus—Lisinopril—dilated cardiomyopathy	0.00146	0.00155	CcSEcCtD
Hydromorphone—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00141	0.0015	CcSEcCtD
Hydromorphone—Dizziness—Lisinopril—dilated cardiomyopathy	0.00137	0.00145	CcSEcCtD
Hydromorphone—Vomiting—Lisinopril—dilated cardiomyopathy	0.00131	0.00139	CcSEcCtD
Hydromorphone—Rash—Lisinopril—dilated cardiomyopathy	0.0013	0.00138	CcSEcCtD
Hydromorphone—Dermatitis—Lisinopril—dilated cardiomyopathy	0.0013	0.00138	CcSEcCtD
Hydromorphone—Headache—Lisinopril—dilated cardiomyopathy	0.0013	0.00137	CcSEcCtD
Hydromorphone—Nausea—Lisinopril—dilated cardiomyopathy	0.00123	0.0013	CcSEcCtD
Hydromorphone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	0.00107	0.0192	CbGpPWpGaD
Hydromorphone—OPRD1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.000996	0.018	CbGpPWpGaD
Hydromorphone—OPRK1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.000939	0.0169	CbGpPWpGaD
Hydromorphone—OPRD1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000939	0.0169	CbGpPWpGaD
Hydromorphone—OPRK1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.000873	0.0157	CbGpPWpGaD
Hydromorphone—OPRD1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.000824	0.0149	CbGpPWpGaD
Hydromorphone—OPRK1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000824	0.0148	CbGpPWpGaD
Hydromorphone—OPRM1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.000794	0.0143	CbGpPWpGaD
Hydromorphone—OPRM1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.000738	0.0133	CbGpPWpGaD
Hydromorphone—OPRK1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.000722	0.013	CbGpPWpGaD
Hydromorphone—OPRM1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000696	0.0125	CbGpPWpGaD
Hydromorphone—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000669	0.0121	CbGpPWpGaD
Hydromorphone—OPRM1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.000611	0.011	CbGpPWpGaD
Hydromorphone—OPRM1—IL4-mediated signaling events—IL10—dilated cardiomyopathy	0.000589	0.0106	CbGpPWpGaD
Hydromorphone—OPRM1—IL4-mediated signaling events—RPS6KB1—dilated cardiomyopathy	0.000573	0.0103	CbGpPWpGaD
Hydromorphone—PTGS1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000559	0.0101	CbGpPWpGaD
Hydromorphone—OPRD1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.000504	0.00908	CbGpPWpGaD
Hydromorphone—OPRD1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.000504	0.00908	CbGpPWpGaD
Hydromorphone—PTGS1—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.000482	0.00868	CbGpPWpGaD
Hydromorphone—OPRD1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.000468	0.00844	CbGpPWpGaD
Hydromorphone—OPRK1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.000442	0.00797	CbGpPWpGaD
Hydromorphone—OPRK1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.000442	0.00797	CbGpPWpGaD
Hydromorphone—OPRD1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000425	0.00766	CbGpPWpGaD
Hydromorphone—OPRD1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000425	0.00766	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000424	0.00765	CbGpPWpGaD
Hydromorphone—OPRK1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.000411	0.0074	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000399	0.00719	CbGpPWpGaD
Hydromorphone—OPRD1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000395	0.00712	CbGpPWpGaD
Hydromorphone—OPRD1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000394	0.00711	CbGpPWpGaD
Hydromorphone—OPRM1—TCR Signaling Pathway—FAS—dilated cardiomyopathy	0.000392	0.00707	CbGpPWpGaD
Hydromorphone—OPRD1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.000387	0.00698	CbGpPWpGaD
Hydromorphone—OPRM1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.000373	0.00673	CbGpPWpGaD
Hydromorphone—OPRM1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.000373	0.00673	CbGpPWpGaD
Hydromorphone—OPRK1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000373	0.00672	CbGpPWpGaD
Hydromorphone—OPRK1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000373	0.00672	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000373	0.00672	CbGpPWpGaD
Hydromorphone—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000367	0.00661	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000356	0.00641	CbGpPWpGaD
Hydromorphone—UGT1A9—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.000355	0.00641	CbGpPWpGaD
Hydromorphone—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000355	0.0064	CbGpPWpGaD
Hydromorphone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.000348	0.00627	CbGpPWpGaD
Hydromorphone—OPRM1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.000347	0.00626	CbGpPWpGaD
Hydromorphone—OPRK1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000347	0.00625	CbGpPWpGaD
Hydromorphone—OPRK1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000346	0.00624	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000346	0.00623	CbGpPWpGaD
Hydromorphone—OPRK1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.00034	0.00612	CbGpPWpGaD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000338	0.00609	CbGpPWpGaD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000338	0.00609	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000325	0.00586	CbGpPWpGaD
Hydromorphone—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000322	0.0058	CbGpPWpGaD
Hydromorphone—UGT1A9—PPARA activates gene expression—AGT—dilated cardiomyopathy	0.00032	0.00577	CbGpPWpGaD
Hydromorphone—OPRM1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000315	0.00568	CbGpPWpGaD
Hydromorphone—OPRM1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000315	0.00568	CbGpPWpGaD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000314	0.00566	CbGpPWpGaD
Hydromorphone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.000313	0.00565	CbGpPWpGaD
Hydromorphone—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000311	0.00561	CbGpPWpGaD
Hydromorphone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000306	0.00551	CbGpPWpGaD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000304	0.00549	CbGpPWpGaD
Hydromorphone—OPRD1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000303	0.00547	CbGpPWpGaD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000296	0.00534	CbGpPWpGaD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000296	0.00534	CbGpPWpGaD
Hydromorphone—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000294	0.0053	CbGpPWpGaD
Hydromorphone—OPRM1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000293	0.00528	CbGpPWpGaD
Hydromorphone—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000292	0.00527	CbGpPWpGaD
Hydromorphone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000291	0.00525	CbGpPWpGaD
Hydromorphone—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000288	0.00519	CbGpPWpGaD
Hydromorphone—OPRM1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.000287	0.00518	CbGpPWpGaD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000276	0.00497	CbGpPWpGaD
Hydromorphone—OPRD1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.000273	0.00492	CbGpPWpGaD
Hydromorphone—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000272	0.0049	CbGpPWpGaD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000267	0.00481	CbGpPWpGaD
Hydromorphone—OPRK1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000266	0.0048	CbGpPWpGaD
Hydromorphone—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000263	0.00475	CbGpPWpGaD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00026	0.00469	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000257	0.00464	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000257	0.00464	CbGpPWpGaD
Hydromorphone—OPRM1—TCR Signaling Pathway—RAF1—dilated cardiomyopathy	0.000255	0.0046	CbGpPWpGaD
Hydromorphone—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000252	0.00455	CbGpPWpGaD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00025	0.00452	CbGpPWpGaD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00025	0.00452	CbGpPWpGaD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000247	0.00444	CbGpPWpGaD
Hydromorphone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.00024	0.00432	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000239	0.00431	CbGpPWpGaD
Hydromorphone—OPRK1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.000239	0.00431	CbGpPWpGaD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000233	0.0042	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000232	0.00418	CbGpPWpGaD
Hydromorphone—OPRD1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00023	0.00415	CbGpPWpGaD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000228	0.00411	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000226	0.00407	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000226	0.00407	CbGpPWpGaD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000226	0.00407	CbGpPWpGaD
Hydromorphone—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000225	0.00405	CbGpPWpGaD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000216	0.0039	CbGpPWpGaD
Hydromorphone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.000216	0.00389	CbGpPWpGaD
Hydromorphone—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000213	0.00384	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00021	0.00378	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000203	0.00366	CbGpPWpGaD
Hydromorphone—OPRM1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.000202	0.00364	CbGpPWpGaD
Hydromorphone—OPRK1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000202	0.00364	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000198	0.00357	CbGpPWpGaD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000193	0.00347	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000191	0.00344	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000191	0.00344	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—ANKRD1—dilated cardiomyopathy	0.000189	0.00341	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000188	0.00338	CbGpPWpGaD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000183	0.0033	CbGpPWpGaD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000183	0.00329	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000182	0.00328	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—TAZ—dilated cardiomyopathy	0.000178	0.0032	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000177	0.0032	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000174	0.00313	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000172	0.0031	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000171	0.00308	CbGpPWpGaD
Hydromorphone—OPRM1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00017	0.00307	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000165	0.00297	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—SDHA—dilated cardiomyopathy	0.000161	0.0029	CbGpPWpGaD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00016	0.00289	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000154	0.00278	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000147	0.00264	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000145	0.00262	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000145	0.00262	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—TAZ—dilated cardiomyopathy	0.000145	0.00261	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000141	0.00255	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000139	0.00251	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000139	0.00251	CbGpPWpGaD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000136	0.00244	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000135	0.00244	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000132	0.00238	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000132	0.00238	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000131	0.00236	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—SDHA—dilated cardiomyopathy	0.000131	0.00236	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000128	0.0023	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000128	0.0023	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000123	0.00221	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000122	0.0022	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000119	0.00214	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000119	0.00214	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000116	0.00209	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000116	0.00209	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000115	0.00207	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000112	0.00202	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000108	0.00194	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000108	0.00194	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000108	0.00194	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000106	0.00191	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000104	0.00188	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000103	0.00186	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000102	0.00183	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.0001	0.00181	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	9.81e-05	0.00177	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	9.8e-05	0.00177	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	9.79e-05	0.00176	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	9.79e-05	0.00176	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	9.7e-05	0.00175	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	9.64e-05	0.00174	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	9.54e-05	0.00172	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	9.3e-05	0.00168	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	9.1e-05	0.00164	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.91e-05	0.00161	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	8.81e-05	0.00159	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.79e-05	0.00158	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	8.59e-05	0.00155	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.45e-05	0.00152	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	8.29e-05	0.00149	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	8.24e-05	0.00148	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	8.17e-05	0.00147	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	8.1e-05	0.00146	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.99e-05	0.00144	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.87e-05	0.00142	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	7.86e-05	0.00142	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.8e-05	0.00141	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.8e-05	0.00141	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.78e-05	0.0014	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.71e-05	0.00139	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	7.68e-05	0.00138	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	7.61e-05	0.00137	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	7.53e-05	0.00136	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.48e-05	0.00135	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.25e-05	0.00131	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.22e-05	0.0013	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—AGT—dilated cardiomyopathy	7.15e-05	0.00129	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	7.14e-05	0.00129	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—ADRB1—dilated cardiomyopathy	7.02e-05	0.00127	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7e-05	0.00126	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	6.94e-05	0.00125	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.9e-05	0.00124	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	6.88e-05	0.00124	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.84e-05	0.00123	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.84e-05	0.00123	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.56e-05	0.00118	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	6.51e-05	0.00117	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.36e-05	0.00115	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—AGT—dilated cardiomyopathy	6.27e-05	0.00113	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.16e-05	0.00111	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.1e-05	0.0011	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	6e-05	0.00108	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	5.83e-05	0.00105	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.78e-05	0.00104	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.78e-05	0.00104	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.69e-05	0.00103	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.54e-05	0.000999	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.38e-05	0.000969	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	5.34e-05	0.000963	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	5.3e-05	0.000955	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.26e-05	0.000948	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.21e-05	0.000939	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	5.02e-05	0.000905	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.99e-05	0.0009	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.96e-05	0.000894	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.89e-05	0.000882	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	4.54e-05	0.000819	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.45e-05	0.000802	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	4.42e-05	0.000797	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—GPX1—dilated cardiomyopathy	4.36e-05	0.000787	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.35e-05	0.000784	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.29e-05	0.000773	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—CD36—dilated cardiomyopathy	4.25e-05	0.000766	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—AGT—dilated cardiomyopathy	4.22e-05	0.000761	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.22e-05	0.00076	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.2e-05	0.000757	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.09e-05	0.000737	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—RAC1—dilated cardiomyopathy	3.87e-05	0.000699	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—AGT—dilated cardiomyopathy	3.83e-05	0.00069	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—AGT—dilated cardiomyopathy	3.7e-05	0.000667	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.68e-05	0.000664	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.68e-05	0.000663	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.62e-05	0.000653	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GPX1—dilated cardiomyopathy	3.56e-05	0.000641	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—CD36—dilated cardiomyopathy	3.46e-05	0.000625	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.4e-05	0.000613	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	3.27e-05	0.00059	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—AGT—dilated cardiomyopathy	3.13e-05	0.000564	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—AGT—dilated cardiomyopathy	3.12e-05	0.000562	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.98e-05	0.000538	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.93e-05	0.000528	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.57e-05	0.000463	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.52e-05	0.000454	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.17e-05	0.000391	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.01e-05	0.000362	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	1.89e-05	0.00034	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	1.87e-05	0.000337	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	1.84e-05	0.000331	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	1.82e-05	0.000328	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.76e-05	0.000318	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	1.65e-05	0.000298	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	1.64e-05	0.000296	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.49e-05	0.000268	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.23e-05	0.000222	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.2e-05	0.000217	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.08e-05	0.000195	CbGpPWpGaD
